关键词

阿司匹林；地屈孕酮；多囊卵巢综合征；作用机制；治疗方法；优势分析；限制因素

全文

PDF

参考

[1] Legro, R. S., Arslanian, S. A., Ehrmann, D. A., et al. (2013). Diagnosis and treatment of polycystic ovary
syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology &
Metabolism, 98(12), 4565-4592.
[2] Diamanti-Kandarakis, E., Kouli, C. R., Bergiele, A. T., et al. (1999). A survey of the polycystic ovary
syndrome in the Greek island of Lesbos: hormonal and metabolic profile. The Journal of Clinical
Endocrinology & Metabolism, 84(11), 4006-4011.
[3] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus
on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human
Reproduction, 19(1), 41-47.
[4] Escobar-Morreale, H. F., Carmina, E., Dewailly, D., et al. (2012). Epidemiology, diagnosis and
management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome
Society. Human Reproduction Update, 18(2), 146-170.
[5] Pasquali, R., Casimirri, F., Venturoli, S., Antonio, M., Paradisi, R., & Zamboni, M. (1994). Body fat
distribution has weight-independent effects on clinical, hormonal and metabolic features of women with
polycystic ovary syndrome. Metabolism, 43(6), 706-713.
[6] Franks, S. (1995). Polycystic ovary syndrome. The New England Journal of Medicine, 333(13), 853-861.
[7] Fauser, B. C., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., et al. (2012). Consensus on
women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd
PCOS Consensus Workshop Group. Fertility and Sterility, 97(1), 28-38.e25.
[8] Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011). Polycystic ovary syndrome: etiology,
pathogenesis and diagnosis. Nature Reviews Endocrinology, 7(4), 219-231.